What is Biohaven's available for sale investments?

Biohaven (BHVN) reported available for sale investments of $150.52M in Q1 2026.

How has Biohaven's available for sale investments changed year-over-year?

Biohaven's available for sale investments decreased by 32.9% year-over-year, from $224.33M to $150.52M.

What is the long-term trend for Biohaven's available for sale investments?

Over 3 years (2022 to 2025), Biohaven's available for sale investments has grown at a -28.3% compound annual growth rate (CAGR), from $310.36M to $114.17M.

Biohaven BHVN Available for sale investments

Available for sale investments at other companies

Viridian Therapeutics, Inc.VRDN

——

BiogenBIIB

——

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Enterprise value$2.26B-46.3%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's available for sale investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's available for sale investments?: Biohaven (BHVN) reported available for sale investments of $150.52M in Q1 2026.
How has Biohaven's available for sale investments changed year-over-year?: Biohaven's available for sale investments decreased by 32.9% year-over-year, from $224.33M to $150.52M.
What is the long-term trend for Biohaven's available for sale investments?: Over 3 years (2022 to 2025), Biohaven's available for sale investments has grown at a -28.3% compound annual growth rate (CAGR), from $310.36M to $114.17M.